These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30421652)

  • 1. Treatment patterns, healthcare resource utilization, and healthcare costs among patients with pulmonary arterial hypertension in a real-world US database.
    Studer S; Hull M; Pruett J; Koep E; Tsang Y; Drake W
    Pulm Circ; 2019; 9(1):2045894018816294. PubMed ID: 30421652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using Real World Evidence to Describe Pulmonary Arterial Hypertension Treatment Patterns, Healthcare Resource Utilization, and Costs Associated with PDE-5 Inhibitor Monotherapy.
    Ruiz G; Yeaw J; Lickert CA; De AP; Wade RL; Pruett J; Drake W
    J Health Econ Outcomes Res; 2018; 5(2):206-219. PubMed ID: 35620777
    [No Abstract]   [Full Text] [Related]  

  • 3. Medication adherence, hospitalization, and healthcare resource utilization and costs in patients with pulmonary arterial hypertension treated with endothelin receptor antagonists or phosphodiesterase type-5 inhibitors.
    Frantz RP; Hill JW; Lickert CA; Wade RL; Cole MR; Tsang Y; Drake W
    Pulm Circ; 2020; 10(1):2045894019880086. PubMed ID: 32274010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world treatment patterns, healthcare resource utilization, and cost among adults with pulmonary arterial hypertension in the United States.
    Pizzicato LN; Nadipelli VR; Governor S; Mao J; Lanes S; Butler J; Pepe RS; Phatak H; El-Kersh K
    Pulm Circ; 2022 Apr; 12(2):e12090. PubMed ID: 35795495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment patterns and healthcare system burden of managed care patients with suspected pulmonary arterial hypertension in the United States.
    Copher R; Cerulli A; Watkins A; Laura Monsalvo M
    J Med Econ; 2012; 15(5):947-55. PubMed ID: 22554140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective Database Analysis of Treatment Patterns Among Patients with Pulmonary Arterial Hypertension.
    Studer S; Hull M; Pruett J; Elliott C; Tsang Y; Drake W
    Pulm Ther; 2020 Jun; 6(1):79-92. PubMed ID: 32048240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
    Baser O; Andrews LM; Wang L; Xie L
    J Med Econ; 2011; 14(5):576-83. PubMed ID: 21728914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.
    Sheehan DV; Keene MS; Eaddy M; Krulewicz S; Kraus JE; Carpenter DJ
    CNS Drugs; 2008; 22(11):963-73. PubMed ID: 18840035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence and treatment patterns of disease-specific drugs among patients with pulmonary arterial hypertension: A nationwide, new-user cohort study.
    Tsai CY; Shen CW; Lai HL; Chen CY
    Front Pharmacol; 2022; 13():1030693. PubMed ID: 36712686
    [No Abstract]   [Full Text] [Related]  

  • 10. Healthcare resource utilization and costs for patients with pulmonary arterial hypertension: real-world documentation of functional class.
    Dufour R; Pruett J; Hu N; Lickert C; Stemkowski S; Tsang Y; Lane D; Drake W
    J Med Econ; 2017 Nov; 20(11):1178-1186. PubMed ID: 28762848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world health outcomes in adults with moderate-to-severe psoriasis in the United States: a population study using electronic health records to examine patient-perceived treatment effectiveness, medication use, and healthcare resource utilization.
    Armstrong AW; Foster SA; Comer BS; Lin CY; Malatestinic W; Burge R; Goldblum O
    BMC Dermatol; 2018 Jun; 18(1):4. PubMed ID: 29954363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Migraine-related healthcare resource use and costs for subjects prescribed fixed-dose combination sumatriptan/naproxen sodium vs. single-entity oral triptans in a managed care population in the USA.
    Runken MC; Goodwin B; Shah M; Eaddy M; D'Souza A; Bowers B; Bell CF
    Appl Health Econ Health Policy; 2015 Feb; 13(1):109-20. PubMed ID: 25294555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment patterns, healthcare resource utilization, and costs following first-line antidepressant treatment in major depressive disorder: a retrospective US claims database analysis.
    Gauthier G; Guérin A; Zhdanava M; Jacobson W; Nomikos G; Merikle E; François C; Perez V
    BMC Psychiatry; 2017 Jun; 17(1):222. PubMed ID: 28629442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High rates of medication adherence in patients with pulmonary arterial hypertension: An integrated specialty pharmacy approach.
    Shah NB; Mitchell RE; Proctor ST; Choi L; DeClercq J; Jolly JA; Hemnes AR; Zuckerman AD
    PLoS One; 2019; 14(6):e0217798. PubMed ID: 31170217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment patterns and resource utilization and costs among patients with pulmonary arterial hypertension in the United States.
    Angalakuditi M; Edgell E; Beardsworth A; Buysman E; Bancroft T
    J Med Econ; 2010; 13(3):393-402. PubMed ID: 20608882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare utilization and costs of children with attention deficit/hyperactivity disorder initiating atomoxetine versus extended-release guanfacine.
    Molife C; Haynes VS; Nyhuis A; Faries DE; Gelwicks S; Kelsey DK; Alatorre CI
    Curr Med Res Opin; 2018 Apr; 34(4):619-632. PubMed ID: 29298540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment Patterns, Healthcare Resource Utilization and Costs Among Schizophrenia Patients Treated with Long-Acting Injectable Versus Oral Antipsychotics.
    Shah A; Xie L; Kariburyo F; Zhang Q; Gore M
    Adv Ther; 2018 Nov; 35(11):1994-2014. PubMed ID: 30269292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication Adherence and Healthcare Costs Among Patients with Pulmonary Arterial Hypertension Treated with Oral Prostacyclins: A Retrospective Cohort Study.
    Dean BB; Saundankar V; Stafkey-Mailey D; Anguiano RH; Nelsen AC; Gordon K; Classi P
    Drugs Real World Outcomes; 2020 Sep; 7(3):229-239. PubMed ID: 32144746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline history of patients using selexipag for pulmonary arterial hypertension.
    Highland KB; Hull M; Pruett J; Elliott C; Tsang Y; Drake W
    Ther Adv Respir Dis; 2019; 13():1753466619843774. PubMed ID: 30983530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of amlodipine/valsartan/hydrochlorothiazide single pill combination and free combination: adherence, persistence, healthcare utilization and costs.
    Machnicki G; Ong SH; Chen W; Wei ZJ; Kahler KH
    Curr Med Res Opin; 2015 Dec; 31(12):2287-96. PubMed ID: 26397178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.